Boulding Mark Elliott sold PTCT
February 17, 2026 · Form 4 insider transaction
Boulding Mark Elliott sold 2 shares of PTC Therapeutics, Inc. at $70.13 per share, a transaction worth $140.26. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2
Price
$70.13
Total value
$140.26
InsiderBoulding Mark Elliott
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 17, 2026
Filing dateFebruary 19, 2026
Shares owned after111,312
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024.